OD-OS MacuTherm

CompanyGermany

OD-OS MacuTherm develops one asset, in human trials (Navilas Laser System in intermediate AMD). Mostly device; based in Germany.

1
Asset
Furthest stage: Human trials; 1
Trial: 0
Signals

Pipeline

1

Navilas Laser System
Delivers individually dosed photothermal therapy to preserve photoreceptors and reduce progression of intermediate age-related macular degeneration.
Human trials, Device, intermediate AMD

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Signals1